Psoriasis in the transplant population

Arch Dermatol Res. 2023 Jul;315(5):1109-1128. doi: 10.1007/s00403-022-02487-0. Epub 2022 Dec 2.

Abstract

Solid organ and stem cell transplants are increasingly common, and dermatologists will more frequently encounter and need to manage common skin diseases, such as psoriasis, in transplant patients. This review explores psoriasis remission and occurrence in recipients of solid organ and stem cell transplants. Hematopoietic and mesenchymal stem cell transplants may show potential for treating psoriasis in patients with leukemia or who have other medical conditions requiring stem cell transplant. The effects of solid organ transplant are less clear, partly due to limitations in the breadth of the literature. De novo psoriasis has been reported in recipients of solid organ transplants, but the reasons for this development have yet to be fully understood. Overall, the literature on this subject is limited to primarily case reports. Feasibility of studies on the subject may be a considerable barrier to further research assessing the use of transplant for treating psoriasis, but there is potential benefit from transplant for psoriasis patients. This subject should receive further exploration to fully understand these benefits.

Keywords: Organ; Psoriasis; Review; Stem cell; Therapy; Transplant.

Publication types

  • Review

MeSH terms

  • Humans
  • Mesenchymal Stem Cells*
  • Organ Transplantation*
  • Psoriasis*
  • Stem Cell Transplantation